ScholarIQanswers from OpenAlex & ORCID
Britta Siegmund
ResearcherPublications, citations & collaboration network
Britta Siegmund is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Britta Siegmund have?
ScholarIQindexed works
Britta Siegmund has 949 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Britta Siegmund have?
ScholarIQcitation count
Britta Siegmund has 25,353 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Britta Siegmund?
ScholarIQh-index
Britta Siegmund has an h-index of 80 in OpenAlex.
What is the i10-index of Britta Siegmund?
ScholarIQi10-index
Britta Siegmund has an i10-index of 282 in OpenAlex.
What is the ORCID of Britta Siegmund?
ScholarIQorcid
The ORCID for Britta Siegmund is on the source record.
What is the OpenAlex record for Britta Siegmund?
ScholarIQopenalex
The OpenAlex for Britta Siegmund is on the source record.
What are the most-cited papers on Britta Siegmund?
ScholarIQmost cited works
Ulcerative colitis
Taku Kobayashi, Britta Siegmund, Catherine Le Berre, Shu Chen Wei, Marc Ferrante, Bo Shen, Charles N. Bernstein, Silvio Danese, Laurent Peyrin‐Biroulet, Toshifumi Hibi∥
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19
Jenny Meinhardt, Josefine Radke, Carsten Dittmayer, Jonas Franz, Carolina Thomas, Ronja Mothes, Michael Laue, Julia Schneider, Sebastian Brünink, Selina Greuel, Malte Lehmann, Olga Hassan, Tom Aschman, Elisa Schumann, Robert Lorenz Chua, Christian Conrad, Roland Eils, Werner Stenzel, Marc Windgassen, Larissa Rößler, Hans‐Hilmar Goebel, Hans R. Gelderblom, Hubert Martin, Andreas Nitsche, Walter Schulz‐Schaeffer, Samy Hakroush, Martin Sebastian Winkler, Björn Tampe, Franziska Scheibe, Péter Körtvelyessy, Dirk Reinhold, Britta Siegmund, Anja A. Kühl, Sefer Elezkurtaj, David Horst, Lars Oesterhelweg, Michael Tsokos, Barbara Ingold‐Heppner, Christine Stadelmann, Christian Drosten, Victor M. Corman, Helena Radbruch, Frank L. Heppner
Management of Patients With Crohn’s Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting
David T. Rubin, María T. Abreu, Victoria Rai, Corey A. Siegel, Vineet Ahuja, Matthieu Allez, Ashwin N. Ananthakrishnan, Çharles N. Bernstein, Jonathan Braun, Yehuda Chowers, Jean‐Frédéric Colombel, Silvio Danese, Geert D’Haens, André D’Hoore, Axel Dignaß, Iris Dotan, Marla C. Dubinsky, Anders Ekbom, Phillip Fleshner, Miquel A. Gassull, Richard B. Gearry, Subrata Ghosh, Anne M. Griffiths, Jonas Halfvarson, Stephen B. Hanauer, Noam Harpaz, Ailsa Hart, Michael A. Kamm, Gilaad G. Kaplan, Ioannis E. Κoutroubakis, Péter L. Lakatos, Arie Levine, James D. Lewis, James O. Lindsay, Edward V. Loftus, Édouard Louis, Milan Lukáš, Fernando Magro, Uma Mahadevan, Gerasimos J. Mantzaris, Dermot McGovern, Bjørn Moum, Pia Munkholm, Markus F. Neurath, Siew C. Ng, Colm O’Morain, Remo Panaccione, Julián Panés, Laurent Peyrin‐Biroulet, Cosimo Prantera, Zhihua Ran, Walter Reinisch, Feza H. Remzi, David B. Sachar, William J. Sandborn, R. Balfour Sartor, Jürgen Schölmerich, Stefan Schreiber, Britta Siegmund, Mark S. Silverberg, Johan D. Söderholm, Eduard F. Stange, Flávio Steinwurz, Dan Turner, Morten H. Vatn, Séverine Vermeire, Erica J. Brenner, Britt Christensen, Ferdinando D’Amico, C. Griffiths, Peter Higgins, Michael D. Kappelman, Charlie W. Lees, Miguel Regueiro, Joel R. Rosh, Ryan C. Ungaro
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study
Andreas Stallmach, C. Langbein, Raja Atreya, Tony Bruns, Axel Dignaß, K Ende, Jochen Hampe, Franz Hartmann, Markus F. Neurath, Jochen Maul, J. Preiß, Renate Schmelz, Britta Siegmund, H Schulze, Niels Teich, Ulrike von Arnim, Daniel C. Baumgart, Carsten Schmidt